273 related articles for article (PubMed ID: 25703822)
1. Methamphetamine promotes α-tubulin deacetylation in endothelial cells: the protective role of acetyl-l-carnitine.
Fernandes S; Salta S; Summavielle T
Toxicol Lett; 2015 Apr; 234(2):131-8. PubMed ID: 25703822
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-L-Carnitine Prevents Methamphetamine-Induced Structural Damage on Endothelial Cells via ILK-Related MMP-9 Activity.
Fernandes S; Salta S; Bravo J; Silva AP; Summavielle T
Mol Neurobiol; 2016 Jan; 53(1):408-422. PubMed ID: 25465237
[TBL] [Abstract][Full Text] [Related]
3. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
4. PBN inhibits a detrimental effect of methamphetamine on brain endothelial cells by alleviating the generation of reactive oxygen species.
Hwang JS; Cha EH; Park B; Ha E; Seo JH
Arch Pharm Res; 2020 Dec; 43(12):1347-1355. PubMed ID: 33200316
[TBL] [Abstract][Full Text] [Related]
5. HDAC6 is a microtubule-associated deacetylase.
Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
[TBL] [Abstract][Full Text] [Related]
6. Prolactin protects against the methamphetamine-induced cerebral vascular toxicity.
Rosas-Hernandez H; Cuevas E; Lantz SM; Ali SF; Gonzalez C
Curr Neurovasc Res; 2013 Nov; 10(4):346-55. PubMed ID: 23988027
[TBL] [Abstract][Full Text] [Related]
7. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6.
Zilberman Y; Ballestrem C; Carramusa L; Mazitschek R; Khochbin S; Bershadsky A
J Cell Sci; 2009 Oct; 122(Pt 19):3531-41. PubMed ID: 19737819
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells.
Ramirez SH; Potula R; Fan S; Eidem T; Papugani A; Reichenbach N; Dykstra H; Weksler BB; Romero IA; Couraud PO; Persidsky Y
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1933-45. PubMed ID: 19654589
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation.
Nam HJ; Kang JK; Kim SK; Ahn KJ; Seok H; Park SJ; Chang JS; Pothoulakis C; Lamont JT; Kim H
J Biol Chem; 2010 Oct; 285(43):32888-32896. PubMed ID: 20696758
[TBL] [Abstract][Full Text] [Related]
10. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of neuropeptide Y2 receptor activation against methamphetamine-induced brain endothelial cell alterations.
Ventura F; Muga M; Coelho-Santos V; Fontes-Ribeiro CA; Leitão RA; Silva AP
Toxicol Lett; 2020 Nov; 334():53-59. PubMed ID: 32956829
[TBL] [Abstract][Full Text] [Related]
12. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
13. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
14. Peripheral ammonia and blood brain barrier structure and function after methamphetamine.
Northrop NA; Halpin LE; Yamamoto BK
Neuropharmacology; 2016 Aug; 107():18-26. PubMed ID: 26972828
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9.
Martins T; Baptista S; Gonçalves J; Leal E; Milhazes N; Borges F; Ribeiro CF; Quintela O; Lendoiro E; López-Rivadulla M; Ambrósio AF; Silva AP
Brain Res; 2011 Sep; 1411():28-40. PubMed ID: 21803344
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway.
Xue Y; He JT; Zhang KK; Chen LJ; Wang Q; Xie XL
Biochem Biophys Res Commun; 2019 Feb; 509(2):395-401. PubMed ID: 30594393
[TBL] [Abstract][Full Text] [Related]
18. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.
Ma J; Wan J; Meng J; Banerjee S; Ramakrishnan S; Roy S
Cell Death Dis; 2014 Mar; 5(3):e1099. PubMed ID: 24603327
[TBL] [Abstract][Full Text] [Related]
20. GKT136901 protects primary human brain microvascular endothelial cells against methamphetamine-induced blood-brain barrier dysfunction.
Hwang JS; Cha EH; Ha E; Park B; Seo JH
Life Sci; 2020 Sep; 256():117917. PubMed ID: 32525001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
